Lilly will expand its recently acquired manufacturing facility in Wisconsin with a $3 billion investment, and Amgen will expand its North Carolina facility with a $1 billion investment.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Cambrex and Lilly Sign Agreement to Support Manufacturing for Biotech Collaborators

By Feliza Mirasol

December 5th 2024

Cambrex will provide Lilly’s biotech collaborators with accelerated access to clinical development capabilities.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – stock.adobe.com

Roche Enters Definitive Merger Agreement to Acquire Poseida Therapeutics

By Felicity Thomas

November 29th 2024

The acquisition will provide Roche with access to Poseida’s GMP manufacturing capabilities and R&D portfolio assets, including cell therapy candidates.

Fujifilm Completes Expansion of Cell Therapy Facility

By Nicholas Saraceno

November 22nd 2024

The company officially launched new production suites, a revamp of its development labs, and more at its Thousand Oaks, Calif., cell therapy manufacturing facility.

Pii Invests $3.6 Million to Boost Prefilled Syringe Capabilities

By Nicholas Saraceno

November 22nd 2024

With this $3.6 million investment, the CDMO will strengthen its advanced labeling, automated visual inspection, and fill/finish technology.

More News

Mason Ailstock Preview

Grant Playter

June 1st 2003

...

45 46 47 48 49

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777